We are live on ! Find out more
FRA

Front Row Advisors Portfolio holdings

AUM $296M
1-Year Est. Return 34.73%
This Fund
S&P 500
This Quarter Est. Return
+3.24%
1 Year Est. Return
+34.73%
3 Year Est. Return
+122.22%
5 Year Est. Return
+164.22%
10 Year Est. Return
–
AUM
$137M
AUM Growth
+$8.91M
Cap. Flow
+$5.42M
Cap. Flow %
3.95%
Top 10 Hldgs %
25.75%
Holding
1,127
New
41
Increased
160
Reduced
183
Closed
74

Top Buys

Rank Stock Value
1
MDT icon
Medtronic
MDT
+$2.38M
2
BEAT
BioTelemetry, Inc.
BEAT
+$1.32M
3
RPM icon
RPM International
RPM
+$798K
4
DIS icon
Walt Disney
DIS
+$758K
5
COST icon
Costco
COST
+$641K

Top Sells

Rank Stock Value
1
IRBT
iRobot
IRBT
+$1.7M
2
MDSO
Medidata Solutions, Inc.
MDSO
+$958K
3
MSFT icon
Microsoft
MSFT
+$206K
4
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$129K
5
AAPL icon
Apple
AAPL
+$111K

Sector Composition

Rank Sector Weight
1 Technology 27.32%
2 Healthcare 15.28%
3 Financials 10.67%
4 Consumer Staples 7.75%
5 Consumer Discretionary 5.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ZTS icon
301
Zoetis
ZTS
$31.6B
$23K 0.02%
207
-10
-5% -$1.05K
FLOW
302
DELISTED
SPX FLOW, Inc.
FLOW
$23K 0.02%
544
– –
EV
303
DELISTED
Eaton Vance Corp.
EV
$23K 0.02%
526
– –
EEMV icon
304
iShares MSCI Emerging Markets Min Vol Factor ETF
EEMV
$3.46B
$22K 0.02%
368
– –
HYG icon
305
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$16.3B
$22K 0.02%
249
-91
-27% -$7.86K
KEY icon
306
KeyCorp
KEY
$24.4B
$22K 0.02%
1,227
– –
MAS icon
307
Masco
MAS
$15.8B
$22K 0.02%
556
– –
ALB icon
308
Albemarle
ALB
$13.8B
$21K 0.02%
290
– –
EMN icon
309
Eastman Chemical
EMN
$7.8B
$21K 0.02%
267
– –
IT icon
310
Gartner
IT
$9.22B
$21K 0.02%
131
– –
QQQE icon
311
Direxion NASDAQ-100 Equal Weighted Index ETF
QQQE
$1.34B
$21K 0.02%
430
– –
RGA icon
312
Reinsurance Group of America
RGA
$15.5B
$21K 0.02%
135
– –
SABR icon
313
Sabre
SABR
$676M
$21K 0.02%
936
– –
SHM icon
314
State Street SPDR Nuveen ICE Short Term Municipal Bond ETF
SHM
$3.46B
$21K 0.02%
423
– –
AFL icon
315
Aflac
AFL
$63.6B
$20K 0.01%
372
-116
-24% -$5.98K
AME icon
316
Ametek
AME
$55.6B
$20K 0.01%
218
– –
AVT icon
317
Avnet
AVT
$7.34B
$20K 0.01%
432
– –
DWX icon
318
State Street SPDR S&P International Dividend ETF
DWX
$520M
$20K 0.01%
501
-308
-38% -$11.9K
FLTR icon
319
VanEck IG Floating Rate ETF
FLTR
$2.92B
$20K 0.01%
800
– –
PEP icon
320
PepsiCo
PEP
$184B
$20K 0.01%
156
-7
-4% -$897
SEE
321
DELISTED
Sealed Air
SEE
$20K 0.01%
469
– –
RDS.B
322
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
$20K 0.01%
302
-6
-2% -$390
ATI icon
323
ATI
ATI
$27.4B
$19K 0.01%
735
– –
CVS icon
324
CVS Health
CVS
$138B
$19K 0.01%
353
– –
DECK icon
325
Deckers Outdoor
DECK
$12.8B
$19K 0.01%
648
– –
11 12
13
14 15

Similar funds

SM
Skaana Management Brooklyn, New York $296M AUM 65.1% 1-Year Est. Return
RHP
Royal Harbor Partners Houston, Texas $295M AUM 14.06% 1-Year Est. Return
MSWM
Master's Wealth Management Lancaster, Pennsylvania $295M AUM 15.96% 1-Year Est. Return
RLIM
Red Lighthouse Investment Management New York $296M AUM 22.04% 1-Year Est. Return
JCM
Jacobsen Capital Management Salt Lake City, Utah $296M AUM 24.47% 1-Year Est. Return
CA
Claar Advisors New York $295M AUM 12.26% 1-Year Est. Return
KNFPWM
Keeler & Nadler Financial Planning & Wealth Management Dublin, Ohio $295M AUM 18.48% 1-Year Est. Return
NRC
New Republic Capital Charlotte, North Carolina $297M AUM 24.5% 1-Year Est. Return

Front Row Advisors's Q2 2019 Portfolio in Review

As of Q2 2019, Front Row Advisors held 1,127 positions worth $137M, up 6.9% from $128M the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Front Row Advisors deployed $5.42M of net new capital in Q2 2019, opening 41 new positions and adding to 160 existing holdings. Its largest new stake was BioTelemetry, Inc.: 25,089 shares worth $1.21M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 28% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Microsoft, an estimated $206K trimmed.

  • Front Row Advisors's largest Q2 2019 buy was BioTelemetry, Inc.: 25,089 shares worth $1.21M.
  • Front Row Advisors added most to Medtronic in Q2 2019, an estimated $2.38M increase.
  • Front Row Advisors's biggest Q2 2019 reduction was Microsoft, cutting an estimated $206K.
  • Front Row Advisors fully exited iRobot in Q2 2019, selling an estimated $1.7M.
  • Front Row Advisors's ten largest holdings make up 26% of its $137M portfolio in Q2 2019.
  • Front Row Advisors opened 41 new positions and closed 74 in Q2 2019.
  • Front Row Advisors's portfolio value rose 6.9% quarter-over-quarter to $137M.

Based on Front Row Advisors's 13F filing for Q2 2019, filed 27 Aug 2019.